As many smaller providers have exited the market in recent years, some of the nation’s largest nursing homes chains have benefited by picking up buildings and beds that give them entry  into critical ...

SickKids is providing the C-GUIDE™ tool evaluation of iHope's genomic testing for the diagnosis, care, and well-being ...

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

McKesson Pharmacy Systems & Automation has released its McKesson Clinical Programs Solution, a new platform designed to allow pharmacists the ability to create customized wellness programs. The ...

Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy according to hedge funds. On January 23, Bausch Health announced the results of its global Phase 3 RED-C ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

NYU Langone’s Department of Psychiatry offers the Research Career Development Track for residents who are exploring their research interests.

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

Agreed updates to the trial protocol include the removal of the maximum dosing limit and to allow flexibility in dosing ...

March 23-25, 2026 | San Diego, CA The 11th Innate Killer Summit returns, bringing together global leaders advancing natural killer (NK) cell–based immunotherapies. The meeting continues as the longest ...

Novel KIF18A inhibitor, ATX-295, shows enriched activity in ovarian and TNBC preclinical models with whole genome doubling First-in-class DHX9 inhibitor, ATX-559, demonstrates potent activity in ...